Hair & Skin
About 40% of women will experience noticeable hair thinning by age 50. For many, it starts earlier. Despite how common this is, women's hair loss is routinely dismissed — by providers, by the culture, and often by the women experiencing it, who describe feeling like they're being vain for caring about a change that is genuinely distressing. Hair loss is a real medical concern with real medical treatments.
The most common cause in women is female-pattern hair loss, also called androgenetic alopecia. It's genetic, hormonally influenced, and progressive if untreated. It typically shows up as diffuse thinning across the top and crown rather than the receding hairline seen in men. The part widens. The density visibly decreases. Scalp becomes more visible under lighting.
A second common cause is telogen effluvium — a temporary shedding that follows a physiological stressor. Pregnancy, childbirth, surgery, severe illness, crash dieting, starting or stopping certain medications, major emotional stress. The shedding usually starts about three months after the trigger and resolves within six to nine months. The hair grows back.
Undiagnosed thyroid dysfunction and iron deficiency are both common, correctable causes of hair loss in women. Any serious evaluation of hair loss should include a TSH, a complete blood count, and a ferritin level at minimum.
Declining estrogen in perimenopause and menopause affects hair — often thinning on the scalp and sometimes new hair growth on the face. These hormonal hair changes can respond to HRT in some women and to targeted hair-loss treatment in others.
Topical minoxidil is the most-studied hair-loss treatment and remains first-line. It's FDA-approved for female-pattern hair loss at 2% and 5% concentrations. Most women see results in 3-6 months with consistent daily use. The results are real, but they depend on continued use — stopping treatment means losing the gains over the following months.
Oral minoxidil at low doses (0.625 mg to 2.5 mg daily) has emerged over the last several years as an effective alternative or addition to topical. It's used off-label for hair loss but has good safety data at these low doses and is easier to use consistently than topical formulations.
Oral spironolactone is often added for women with androgen-driven hair loss. It's used off-label for this purpose at doses of 50-200 mg daily. It's particularly useful in women who also have hormonal acne or excess facial hair.
Finasteride is used off-label in women, typically postmenopausal, at low doses. It's not used in women of reproductive age due to risks to a potential pregnancy.
Low-level laser therapy devices have modest evidence and low risk. They work best as adjuncts to medication rather than as standalone treatments.
Biotin supplements. There's almost no evidence they help hair loss in people who aren't biotin-deficient, and most people aren't.
Expensive "hair growth" shampoos and serums without minoxidil in them.
Hair vitamins generally. They make for good gifts and not much else.
Hair loss treatments work best when started before significant density has been lost. Minoxidil thickens existing follicles and can reactivate some miniaturized follicles, but it can't regrow hair from follicles that have been dormant for years. The sooner treatment starts, the more hair it can preserve.
Most dermatologists and primary care physicians can prescribe these treatments, but many don't proactively discuss them with women who bring hair loss concerns. If you're told it's "just genetic" and nothing can be done, that is not correct. Multiple treatments have good evidence. A provider who knows the field can help match the right treatment to your pattern of loss.
Ready to get real answers about your health?
Join the Waitlist — Get 50% OffRead next: The Complete Guide to Tretinoin for Women · How Online Prescriptions Actually Work for Women · Main topic: Hair & Skin